Czech National Bank Acquires 931 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Czech National Bank grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 5.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,638 shares of the biotechnology company's stock after buying an additional 931 shares during the quarter. Czech National Bank's holdings in Axon Enterprise were worth $8,751,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Fourth Dimension Wealth LLC bought a new stake in Axon Enterprise in the fourth quarter valued at $30,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise in the 4th quarter worth about $45,000. Elequin Capital LP bought a new stake in Axon Enterprise during the fourth quarter worth about $46,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise in the 4th quarter valued at $53,000. Finally, GPS Wealth Strategies Group LLC boosted its stake in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Bank of America boosted their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Needham & Company LLC raised their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Finally, Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,969 shares of company stock valued at $29,909,594 over the last three months. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Trading Up 1.1%

NASDAQ AXON traded up $8.36 on Thursday, reaching $788.36. The company had a trading volume of 668,328 shares, compared to its average volume of 732,422. Axon Enterprise, Inc. has a 52 week low of $276.92 and a 52 week high of $793.24. The stock's 50 day moving average is $633.63 and its 200-day moving average is $613.89. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $61.37 billion, a price-to-earnings ratio of 203.71, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise's revenue for the quarter was up 31.3% on a year-over-year basis. During the same period last year, the company posted $1.15 EPS. Equities analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.